Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06145139

KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial

Sponsor: University of Aarhus

View on ClinicalTrials.gov

Summary

The overall aim of this observational study is to confirm that circulating tumor DNA (ctDNA) detected in plasma and or urine after intended curative treatment for renal cell carcinoma (RCC) can be applied in clinical practice as a marker of subclinical residual disease and risk of recurrence.

Official title: KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2023-06-01

Completion Date

2033-06-01

Last Updated

2023-11-22

Healthy Volunteers

No

Conditions

Locations (1)

Urology Department Aarhus University Hospital

Aarhus N, Denmark